Redhill Biopharma Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Redhill Biopharma Ltd., a foreign private issuer based in Tel Aviv, Israel, on January 10, 2014. The report covers the month of January 2014 and is incorporated by reference into the Company's Registration Statement on Form S-8 filed on May 2, 2013.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is informational regarding upcoming corporate events rather than a financial results announcement.
Material Changes
No material changes to financial position or operations were reported in this filing. The document serves to disclose the Company's participation in upcoming industry conferences.
Outlook and Management Commentary
Management indicated that the Company expects to meet with individuals from the financial and pharmaceutical sectors during the 32nd Annual J.P. Morgan Healthcare Conference and the Biotech Showcase 2014 Conference. These events are scheduled to take place in San Francisco, California, from January 13-16, 2014. A copy of the presentation materials was made available on the Company's investor relations website.
Key Facts for Investor Verification
- Verify the content of the presentation materials uploaded to the Company's website at http://ir.redhillbio.com/events.cfm.
- Confirm the Company's participation schedule at the J.P. Morgan Healthcare Conference and Biotech Showcase 2014.
- Note that this filing does not contain updated financial statements or operational metrics.